Mark Wilson, Group Chief Executive Officer, said: “Progress is in line with our expectations and we remain focused on delivering cash flow plus growth. In the first nine months of 2013 our key measure of growth, value of new business, increased by 14%. We had strong performances from France and our growth markets of Turkey, Poland and Asia. Conversely, value of new business remains depressed in our turnaround businesses of Italy and Spain, and this is being addressed. “Capital generation in the period was stable at £1.3 billion and our economic capital surplus now stands at £8 billion. We continue to make satisfactory progress on cost reduction, with operating expenses 10% below the 2011 baseline. “Aviva remains in the early stages of turnaround. Whilst we have resolved a key issue in the disposal of our US business and have made progress in a number of areas, there remains much work to be done.”

1. News Release
Aviva plc
Interim management statement for the nine months to 30 September 2013
07 November 2013
Aviva plc Third Quarter 2013
Interim Management Statement
Mark Wilson, Group Chief Executive Officer, said:
“Progress is in line with our expectations and we remain focused on delivering cash flow plus growth. In the first nine months
of 2013 our key measure of growth, value of new business, increased by 14%. We had strong performances from France and
our growth markets of Turkey, Poland and Asia. Conversely, value of new business remains depressed in our turnaround
businesses of Italy and Spain, and this is being addressed.
“Capital generation in the period was stable at £1.3 billion and our economic capital surplus now stands at £8 billion. We
continue to make satisfactory progress on cost reduction, with operating expenses 10% below the 2011 baseline.
“Aviva remains in the early stages of turnaround. Whilst we have resolved a key issue in the disposal of our US business and
have made progress in a number of areas, there remains much work to be done.”
Cash flow
Operating capital generation stable at £1.3 billion1 (9M12: £1.3 billion)
Continued focus on improving remittance ratios
Full update on cash remittances to be provided at the year end
Expenses
Operating expenses of £2,277 million, 10% lower than our 2011 baseline
Value of new business
Value of new business up 14% to £571 million2 (9M12: £503 million)
Increase driven by France (+33%) and our growth markets of Turkey (+40%), Poland
(+48%) and Asia (+43%)
Growth markets contributed 22% of value of new business (9M12: 18%)
Combined operating ratio
Combined operating ratio stable at 96.9% (9M12: 96.7%)
Balance sheet
Pro forma3 economic capital4 surplus at £8.0 billion (HY13: £7.6 billion)
IFRS net asset value per share 273p (HY13: 281p)
MCEV5 net asset value per share 437p (HY13: 441p)
Completed sale of US business for US$2.6 billion6 (£1.6 billion) in October
1
2
3
4
On a continuing basis. All numbers are continuing unless otherwise stated.
On a continuing basis excluding Malaysia and Sri Lanka.
The pro forma economic capital surplus includes the impact of the US Life transaction and an increase in the risk allowance for staff pension schemes from five to ten years of stressed contributions.
The economic capital surplus represents an estimated position. The capital requirement is based on Aviva’s own internal assessment and capital management policies. The term ‘economic capital’ does not imply
capital as required by regulators or other third parties.
5 In preparing the MCEV information, the directors have done so in accordance with the European Insurance CFO Forum MCEV Principles with the exception of stating held for sale operations at their expected fair
value, as represented by expected sale proceeds, less cost to sell.
6 Transactional proceeds include repayment of an external loan of US$290 million.

2. 2
Aviva plc
Interim Management Statement
07 November 2013
Key financial metrics
Operating Capital Generation
9 months
2013
£bn
9 months
2012
£bn
United Kingdom & Ireland life
United Kingdom & Ireland general insurance & health
Europe
Canada
Asia & Other
0.4
0.3
0.5
0.1
—
0.5
0.3
0.4
0.1
—
Total
1.3
1.3
9 months
2013
£m
9 months
2012
£m
Sterling%
change
Operating expenses
Integration & restructuring costs
2,277
198
2,449
252
(7)%
(21)%
Total expenses
2,475
2,701
(8)%
Continuing operations
9 months
2013
£m
9 months
2012
£m
United Kingdom
Ireland
France
Poland
Italy
Spain
Turkey
Other
Asia1
302
2
112
34
7
19
28
1
66
288
(11)
84
23
19
32
20
2
46
Value of new business – ongoing basis
571
503
14%
1
8
(88)%
572
511
12%
Continuing operations
9 months
2013
9 months
2012
United Kingdom
Ireland
France
Italy
Other Europe
Europe
Canada
95.5%
98.3%
97.4%
95.9%
109.2%
98.3%
95.2%
97.0%
105.3%
94.9%
100.9%
119.8%
99.5%
92.6%
(1.5)pp
(7.0)pp
2.5pp
(5.0)pp
(10.6)pp
(1.2)pp
2.6pp
96.9%
96.7%
0.2pp
30
September
2013
£bn
30 June
2013
£bn
7.4
4.0
273p
437p
7.1
4.2
281p
441p
Continuing Operations
Expenses
Continuing operations
Value of new business
Effect of disposals (Malaysia & Sri Lanka)
Value of new business
Sterling %
change
5%
–
33%
48%
(63)%
(41)%
40%
(50)%
43%
General insurance combined operating ratio
General insurance combined operating ratio
Change
Capital position
Pro forma3
30
September
2013
£bn
Estimated economic capital surplus2
Estimated IGD solvency surplus
IFRS net asset value per share
MCEV4 net asset value per share
1
2
3
4
8.0
3.7
Pro forma3
30 June
2013
£bn
7.6
3.7
Excluding Malaysia and Sri Lanka.
The economic capital surplus represents an estimated position. The capital requirement is based on Aviva’s own internal assessment and capital management policies. The term ‘economic capital’ does not imply capital as required by
regulators or other third parties.
The pro forma economic capital and IGD surpluses include the impact of the US Life transaction and, for economic capital only, an increase in pension scheme risk allowance from five to ten years of stressed contributions.
In preparing the MCEV information, the directors have done so in accordance with the European Insurance CFO Forum MCEV Principles with the exception of stating held for sale operations at their expected fair value, as represented
by expected sale proceeds, less cost to sell.

3. 3
Aviva plc
Interim Management Statement
07 November 2013
Overview
Group Chief Executive Officer’s report
Performance in the first nine months of 2013 has been satisfactory. In line with our investment thesis
of `cash flow plus growth’, operating capital generation was stable and we have increased the value of
new business. We are on track with our cost cutting programme and the combined operating ratio
of our general insurance business was broadly unchanged at 96.9% (9M12: 96.7%).
On the 2nd October we completed the sale of the US business which is an important step in simplifying
Aviva. We also made a number of senior management changes recently to ensure we have the right
team to take Aviva forward.
Operating Capital
Generation
Operating capital
generation stable
at £1.3 billion
Expenses
Operating expenses
of £2,277 million
10% lower than
2011 baseline
Value of new business
Value of new
business up 14%
to £571 million7
Increase driven by
France and our
growth markets
of Poland, Turkey
and Asia
In March we set out Aviva’s investment thesis, `cash flow plus growth’ and our focus is on improving
dividends paid by our business units to Group. Operating capital generation (OCG) is a precursor to
cash remitted to Group and in the first nine months, OCG was stable at £1.3 billion (9M12: £1.3
billion). Lower capital generation due to floods in Canada was more than offset by expense
reductions across Aviva and lower new business strain. Historically the remittance ratios from OCG
to dividends have been materially lower than our peers, and improving this ratio remains an
absolute priority.
Reducing our expense base is essential to the transformation of Aviva and improving cash flows. We
have made further progress in this area, and operating expenses are 10% below the 2011 baseline
expense level and 7% lower year-on-year. We are on track to deliver a cost-base in 2014 which is
£400 million lower than 2011, regardless of the impact of inflation.
Integration and restructuring costs at Aviva have been historically high and an impediment to cash
remitted to Group. In the first nine months of 2013 restructuring costs fell 21% to £198 million. In line
with our previous indications, we expect restructuring costs for 2013 to be lower than the 2012 level of
£461 million and materially lower in 2014.
Value of new business (VNB) is our key measure of growth. Over the first nine months of the year VNB
improved 14% to £571 million7 (9M12: £503 million). In line with our previous guidance we expect
overall growth of VNB to moderate in the final quarter of the year primarily due to a strong 4Q 2012.
Our two major life cash-generators, UK and France, increased VNB by 5% and 33% respectively. In the
UK deliberate actions to improve margin led to an increase in VNB and lower volumes, both in line with
our expectations.
In France, VNB increased 33%. This was mainly driven by outperformance from our AFER network and a
shift in Aviva’s business mix towards higher margin unit linked and protection products across all
channels.
In the first nine months of 2013, our growth markets of Poland, Turkey and Asia7 increased VNB by
48%, 40% and 43% respectively. Collectively, these businesses grew by 44% and contributed 22% of
Group VNB (9M12: 18%).
In Spain and Italy – two of our turnaround businesses – the value of new business fell to £19 million and
£7 million respectively (9M12: £32 million, £19 million). Actions are underway to improve performance
in both of these businesses including focusing more on protection and unit-linked products and
potentially exiting unprofitable distribution agreements.
Combined
operating ratio
COR stable at
96.9%
In general insurance the combined operating ratio (COR) remained stable at 96.9% (9M12: 96.7%)
reflecting the benefit of our geographic diversification. In the UK COR was 95.5%, as a result of lower
expenses and favourable weather conditions. We expect the losses from the UK storms in October to be
in the region of £10 million. In Canada COR was 95.2% despite the impact of two 1:100 year floods.
Across our general insurance businesses in Europe, the COR was 98.3% (9M12: 99.5%) with improved
profitability in Italy and Poland offsetting a deterioration in France mainly due to adverse weather.
Net written premiums in our general insurance and health business were 2% lower at £6,604 million
(9M12: £6,735 million). Growth in Canada was more than offset by a 6% reduction in UK GI volumes
due to a combination of the softening personal lines rate environment and a shift in business mix in UK
motor.
7 On a continuing basis excluding Malaysia and Sri Lanka.

4. 4
Aviva plc
Interim Management Statement
07 November 2013
Balance sheet
IFRS net asset value
per share 273p
Pro forma economic
capital at £8.0
billion
Completed sale of
US business for
US$2.6 billion8
Group Chief Executive Officer’s report continued
The IFRS net asset value per share decreased by 3% to 273p. Profits in the period and additional
proceeds from the sale of the US were offset by foreign exchange movements and a reduction in the
accounting surplus on the Aviva staff pension scheme on an IAS19 basis.
Maintaining a healthy capital position is an important priority and the pro forma economic capital surplus
was £8.0 billion, a coverage ratio of 178%.
In October we completed the sale of Aviva USA, which is an important development for the company.
Transaction proceeds were higher than previously announced at US$2.6 billion8 (£1.6 billion), further
strengthening the Group’s capital position.
Net asset value9
IFRS
Opening NAV per share at 30 June 2013
US disposal
Pension fund
Foreign exchange
Profit and other movements
Closing NAV per share at 30 September 2013
281p
8p
(11)p
(8)p
3p
273p
MCEV
441p
8p
(11)p
(11)p
10p
437p
The balance of our inter-company loan remains unchanged from our last reporting date at £5.1 billion.
We continue to see a substantial reduction in the loan over the next couple of years as one of our key
priorities and remain in active dialogue with our regulator about the ultimate level and the options for
achieving it.
The Polish government’s review of the Pillar II pension system continues. Our current expectation is that
the potential legislative change would reduce our Poland pensions’ value in force (VIF) by between
£150 million and £400 million, in line with our previous guidance. This reduction has not been reflected
in these results due to the continuing significant level of uncertainty.
Management
One of the priorities this year has been to strengthen the senior management team. It is critical that we
have the best possible leadership team so that Aviva can achieve its potential. We have made two
important appointments recently. In September Maurice Tulloch was appointed Chief Executive Officer
of our UK & Ireland general insurance business, and in October Greg Somerville became Chief Executive
of Aviva Canada. Both Maurice and Greg have long track records of success at Aviva. Their
appointments build on the changes that have been made to the senior management team in the first
half of the year.
Outlook
In summary, overall operating performance continues to be satisfactory and Aviva is where I thought it
would be at this point in its transformation. Although the macroeconomic environment is showing signs
of improvement, our plans do not require this. The turnaround at Aviva is still in its infancy; we have
made progress this year and whilst there is room for optimism there remains much to do.
8 Transactional proceeds include repayment of an external loan of US$290 million.
9 Net of tax and non-controlling interests.

5. 5
Aviva plc
Interim Management Statement
07 November 2013
Notes to editors
Notes to editors
All comparators are for the nine months to 30 September 2012
unless otherwise stated.
Income and expenses of foreign entities are translated at
average exchange rates while their assets and liabilities are
translated at the closing rates on 30 September 2013. The
average rates employed in this announcement are 1 euro = £0.85
(9 months to 30 September 2012: 1 euro = £0.81) and US$1 =
£0.65 (9 months to 30 September 2012: US$1 = £0.63).
Growth rates in the press release have been provided
in sterling terms unless stated otherwise. The following
supplement presents this information on both a sterling and
local currency basis.
Cautionary statements:
This should be read in conjunction with the documents filed by
Aviva plc (the “Company” or “Aviva”) with the United States
Securities and Exchange Commission (“SEC”). This
announcement contains, and we may make verbal statements
containing, “forward-looking statements” with respect to certain
of Aviva’s plans and current goals and expectations relating to
future financial condition, performance, results, strategic
initiatives and objectives. Statements containing the words
“believes”, “intends”, “expects”, “plans”, “will,” “seeks”,
“aims”, “may”, “could”, “outlook”, “estimates” and
“anticipates”, and words of similar meaning, are forwardlooking. By their nature, all forward-looking statements involve
risk and uncertainty. Accordingly, there are or will be important
factors that could cause actual results to differ materially from
those indicated in these statements. Aviva believes factors that
could cause actual results to differ materially from those indicated
in forward-looking statements in the presentation include, but
are not limited to: the impact of ongoing difficult conditions in
the global financial markets and the economy generally; the
impact of various local political, regulatory and economic
conditions; market developments and government actions
regarding the sovereign debt crisis in Europe; the effect of credit
spread volatility on the net unrealised value of the investment
portfolio; the effect of losses due to defaults by counterparties,
including potential sovereign debt defaults or restructurings, on
the value of our investments; changes in interest rates that may
cause policyholders to surrender their contracts, reduce the value
of our portfolio and impact our asset and liability matching; the
impact of changes in equity or property prices on our investment
portfolio; fluctuations in currency exchange rates; the effect of
market fluctuations on the value of options and guarantees
embedded in some of our life insurance products and the value
of the assets backing their reserves; the amount of allowances
and impairments taken on our investments; the effect of adverse
capital and credit market conditions on our ability to meet
liquidity needs and our access to capital; a cyclical downturn of
the insurance industry; changes in or inaccuracy of assumptions
in pricing and reserving for insurance business (particularly with
regard to mortality and morbidity trends, lapse rates and policy
renewal rates), longevity and endowments; the impact of
catastrophic events on our business activities and results of
operations; the inability of reinsurers to meet obligations or
unavailability of reinsurance coverage; increased competition in
the UK and in other countries where we have significant
operations; the effect of the European Union’s “Solvency II” rules
on our regulatory capital requirements; the impact of actual
experience differing from estimates used in valuing and
amortising deferred acquisition costs (“DAC”) and acquired value
of in-force business (“AVIF”); the impact of recognising an
impairment of our goodwill or intangibles with indefinite lives;
changes in valuation methodologies, estimates and assumptions
used in the valuation of investment securities; the effect of legal
proceedings and regulatory investigations; the impact of
operational risks, including inadequate or failed internal and
external processes, systems and human error or from external
events; risks associated with arrangements with third parties,
including joint ventures; funding risks associated with our
participation in defined benefit staff pension schemes; the failure
to attract or retain the necessary key personnel; the effect of
systems errors or regulatory changes on the calculation of unit
prices or deduction of charges for our unit-linked products that
may require retrospective compensation to our customers; the
effect of a decline in any of our ratings by rating agencies on our
standing among customers, broker-dealers, agents, wholesalers
and other distributors of our products and services; changes to
our brand and reputation; changes in government regulations or
tax laws in jurisdictions where we conduct business; the inability
to protect our intellectual property; the effect of undisclosed
liabilities, integration issues and other risks associated with our
acquisitions; and the timing impact and other uncertainties
relating to acquisitions and disposals and relating to other future
acquisitions, combinations or disposals within relevant industries.
For a more detailed description of these risks, uncertainties and
other factors, please see Item 3d, “Risk Factors”, and Item 5,
“Operating and Financial Review and Prospects” in Aviva’s
Annual Report Form 20-F as filed with the SEC on 25 March
2013. Aviva undertakes no obligation to update the forward
looking statements in this announcement or any other forwardlooking statements we may make. Forward-looking statements
in this presentation are current only as of the date on which such
statements are made.
Aviva plc is a company registered in England No. 2468686.
Registered office
St Helen's
1 Undershaft
London
EC3P 3DQ
Contacts
Investor contacts
Media contacts
Timings
Colin Simpson
+44 (0)20 7662 8115
Nigel Prideaux
+44 (0)20 7662 0215
Real time media conference call: 07:30 hrs GMT
David Elliot
+44 (0)207 662 8048
Andrew Reid
+44 (0)20 7662 3131
Sarah Swailes
+44 (0)20 7662 6700
Analyst conference call: 08:30 hrs GMT
Tel: +44 (0)20 3427 1917
Conference ID: 8270708

6. 6
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement
1. Trend analysis of VNB (continuing operations) – cumulative
2. Trend analysis of VNB (continuing operations) – discrete
3. Trend analysis of PVNBP (continuing operations) – cumulative
4. Trend analysis of PVNBP (continuing operations) – discrete
5. Trend analysis of PVNBP by product (continuing operations) – cumulative
6. Trend analysis of PVNBP by product (continuing operations) – discrete
7. Geographical analysis of regular and single premiums – life and pensions sales (continuing operations)
8. Trend analysis of Investment sales (continuing operations) – cumulative
9. Trend analysis of Investment sales (continuing operations) – discrete
10. Trend analysis of general insurance and health net written premiums – cumulative
11. Trend analysis of general insurance and health net written premiums – discrete

7. 7
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement continued
1 – Trend analysis of VNB (continuing operations1) – cumulative
Growth on
3Q12 YTD
Gross of tax and non-controlling interests
United Kingdom
Ireland
United Kingdom & Ireland
France
Poland
Italy
Spain
Turkey
Other Europe
Europe
Asia – excluding Malaysia & Sri Lanka
Value of new business – ongoing basis
Effect of disposals (Malaysia & Sri Lanka)
Total value of new business
1Q12 YTD
£m
2Q12 YTD
£m
3Q12 YTD
£m
4Q12 YTD
£m
1Q13 YTD
£m
2Q13 YTD
£m
3Q13 YTD
£m
Sterling
%
5%
118%
10%
33%
48%
(63)%
(41)%
40%
(50)%
12%
43%
Local
currency %
81
(2)
79
35
10
9
14
6
—
74
14
182
(6)
176
62
18
14
21
13
2
130
29
288
(11)
277
84
23
19
32
20
2
180
46
420
(8)
412
119
35
29
56
30
2
271
55
108
(1)
107
39
10
4
5
10
1
69
19
211
1
212
86
21
6
13
20
1
147
41
302
2
304
112
34
7
19
28
1
201
66
5%
118%
10%
27%
42%
(65)%
(44)%
47%
(50)%
7%
38%
167
335
503
738
195
400
571
14%
12%
2
8
8
8
1
1
1
(88)%
(88)%
169
343
511
746
196
401
572
12%
10%
1 Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
2 – Trend analysis of VNB (continuing operations1) – discrete
Growth on
3Q12
Gross of tax and non-controlling interests
United Kingdom
Ireland
United Kingdom & Ireland
France
Poland
Italy
Spain
Turkey
Other Europe
Europe
Asia – excluding Malaysia & Sri Lanka
Value of new business – ongoing basis
Effect of disposals (Malaysia & Sri Lanka)
Total value of new business
1Q12
Discrete
£m
2Q12
Discrete
£m
3Q12
Discrete
£m
4Q12
Discrete
£m
1Q13
Discrete
£m
2Q13
Discrete
£m
3Q13
Discrete
£m
Sterling %
Local
currency %
81
(2)
79
35
10
9
14
6
—
74
14
101
(4)
97
27
8
5
7
7
2
56
15
106
(5)
101
22
5
5
11
7
—
50
17
132
3
135
35
12
10
24
10
—
91
9
108
(1)
107
39
10
4
5
10
1
69
19
103
2
105
47
11
2
8
10
—
78
22
91
1
92
26
13
1
6
8
—
54
25
(14)%
(120)%
(9)%
18%
160%
(80)%
(45)%
14%
—
8%
47%
(14)%
(119)%
(9)%
14%
145%
(81)%
(48)%
16%
—
4%
43%
167
168
168
235
195
205
171
2%
1%
2
6
—
—
1
—
—
—
—
169
174
168
235
196
205
171
2%
1%
1 Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.

8. 8
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement continued
3 – Trend analysis of PVNBP (continuing operations1) – cumulative
Growth on
3Q12 YTD
1Q12 YTD
£m
2Q12 YTD
£m
3Q12 YTD
£m
4Q12 YTD
£m
1Q13 YTD
£m
2Q13 YTD
£m
3Q13 YTD
£m
Life and pensions business
United Kingdom
Ireland
United Kingdom & Ireland
France
Poland
Italy
Spain
Turkey
Other Europe
Europe
Asia – excluding Malaysia & Sri Lanka
Other business3
2,430
199
2,629
1,092
107
673
402
68
56
2,398
418
13
5,387
342
5,729
1,944
201
1,259
705
141
108
4,358
854
30
8,002
469
8,471
2,671
274
1,603
934
212
132
5,826
1,287
79
10,410
632
11,042
3,638
373
1,971
1,295
312
158
7,747
1,673
92
2,336
117
2,453
1,245
123
614
375
135
20
2,512
472
4
4,441
225
4,666
2,373
227
1,305
641
253
20
4,819
845
7
6,657
338
6,995
3,382
358
1,751
813
341
20
6,665
1,243
28
Total life and pensions – ongoing basis
5,458
10,971
15,663
20,554
5,441
10,337
14,931
(5)%
(6)%
24
59
80
92
16
16
16
(80)%
(80)%
5,482
11,030
15,743
20,646
5,457
10,353
14,947
(5)%
(7)%
949
1,934
3,400
4,586
1,134
2,498
3,718
9%
7%
6,431
12,964
19,143
25,232
6,591
12,851
18,665
(2)%
(4)%
Present value of new business premiums 2
Effect of disposals (Malaysia & Sri Lanka)
Total life and pensions
Investment sales4
Total long-term savings sales
1
2
3
4
Sterling %
(17)%
(28)%
(17)%
27%
31%
9%
(13)%
61%
(85)%
14%
(3)%
(65)%
Local
currency %
(17)%
(31)%
(18)%
21%
24%
5%
(16)%
64%
(85)%
10%
(6)%
(65)%
Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
Other business represents the results of Aviva Investors Pooled Pensions.
Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
4 – Trend analysis of PVNBP (continuing operations1) – discrete
Growth on
3Q12
1Q12
Discrete
£m
2Q12
Discrete
£m
3Q12
Discrete
£m
4Q12
Discrete
£m
1Q13
Discrete
£m
2Q13
Discrete
£m
3Q13
Discrete
£m
Life and pensions business
United Kingdom
Ireland
United Kingdom & Ireland
France
Poland
Italy
Spain
Turkey
Other Europe
Europe
Asia – excluding Malaysia & Sri Lanka
Other business3
2,430
199
2,629
1,092
107
673
402
68
56
2,398
418
13
2,957
143
3,100
852
94
586
303
73
52
1,960
436
17
2,615
127
2,742
727
73
344
229
71
24
1,468
433
49
2,408
163
2,571
967
99
368
361
100
26
1,921
386
13
2,336
117
2,453
1,245
123
614
375
135
20
2,512
472
4
2,105
108
2,213
1,128
104
691
266
118
—
2,307
373
3
2,216
113
2,329
1,009
131
446
172
88
—
1,846
398
21
Total life and pensions – ongoing basis
5,458
5,513
4,692
4,891
5,441
4,896
4,594
(2)%
(4)%
24
35
21
12
16
—
—
(100)%
(100)%
5,482
5,548
4,713
4,903
5,457
4,896
4,594
(3)%
(4)%
949
985
1,466
1,186
1,134
1,364
1,220
(17)%
(19)%
6,431
6,533
6,179
6,089
6,591
6,260
5,814
(6)%
(8)%
Present value of new business premiums 2
Effect of disposals (Malaysia & Sri Lanka)
Total life and pensions
Investment sales4
Total long-term savings sales
1
2
3
4
Sterling %
(15)%
(11)%
(15)%
39%
79%
30%
(25)%
24%
(100)%
26%
(8)%
(57)%
Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
Other business represents the results of Aviva Investors Pooled Pensions.
Investment sales are calculated as new single premium plus the annualised value of new regular premiums.
Local
currency %
(15)%
(14)%
(15)%
33%
70%
24%
(28)%
26%
(100)%
21%
(11)%
(57)%

9. 9
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement continued
5 –Trend analysis of PVNBP by product (continuing operations1) – cumulative
Growth on
3Q12 YTD
1Q12 YTD
£m
2Q12 YTD
£m
3Q12 YTD
£m
4Q12 YTD
£m
1Q13 YTD
£m
2Q13 YTD
£m
3Q13 YTD
£m
Life and pensions business
Pensions
Annuities
Bonds
Protection
Equity release
1,251
662
128
300
89
2,762
1,555
253
608
209
3,963
2,459
322
920
338
5,158
3,211
379
1,228
434
1,322
630
33
253
98
2,479
1,217
59
504
182
3,818
1,664
97
781
297
(4)%
(32)%
(70)%
(15)%
(12)%
(4)%
(32)%
(70)%
(15)%
(12)%
United Kingdom
Ireland
2,430
199
5,387
342
8,002
469
10,410
632
2,336
117
4,441
225
6,657
338
(17)%
(28)%
(17)%
(31)%
Present value of new business premiums2
Sterling %
Local
currency %
United Kingdom & Ireland
2,629
5,729
8,471
11,042
2,453
4,666
6,995
(17)%
(18)%
Savings
Protection
1,038
54
1,842
102
2,541
130
3,462
176
1,169
76
2,235
138
3,206
176
26%
35%
21%
30%
France
1,092
1,944
2,671
3,638
1,245
2,373
3,382
27%
21%
180
994
11
121
311
1,836
18
249
430
2,337
25
363
672
2,888
39
510
246
882
11
128
409
1,770
17
250
577
2,353
20
333
34%
1%
(20)%
(8)%
32%
(3)%
(23)%
(11)%
Poland, Italy, Spain & Other Europe
1,306
2,414
3,155
4,109
1,267
2,446
3,283
4%
—
Europe
2,398
4,358
5,826
7,747
2,512
4,819
6,665
14%
10%
418
854
1,287
1,673
472
845
1,243
(3)%
(6)%
13
30
79
92
4
7
28
(65)%
(65)%
5,458
10,971
15,663
20,554
5,441
10,337
14,931
(5)%
(6)%
24
59
80
92
16
16
16
(80)%
(80)%
5,482
11,030
15,743
20,646
5,457
10,353
14,947
(5)%
(7)%
Pensions
Savings
Annuities
Protection
Asia (excluding Malaysia & Sri Lanka)
Other business3
Total life and pensions sales – ongoing basis
Effect of disposals (Malaysia & Sri Lanka)
Total life and pensions
1 Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
2 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
3 Other business represents the results of Aviva Investors Pooled Pensions.
6 – Trend analysis of PVNBP by product (continuing operations1) – discrete
Growth on
3Q12
1Q12
Discrete
£m
2Q12
Discrete
£m
3Q12
Discrete
£m
4Q12
Discrete
£m
1Q13
Discrete
£m
2Q13
Discrete
£m
3Q13
Discrete
£m
Life and pensions business
Pensions
Annuities
Bonds
Protection
Equity release
1,251
662
128
300
89
1,511
893
125
308
120
1,201
904
69
312
129
1,195
752
57
308
96
1,322
630
33
253
98
1,157
587
26
251
84
1,339
447
38
277
115
11%
(51)%
(45)%
(11)%
(11)%
11%
(51)%
(45)%
(11)%
(11)%
United Kingdom
Ireland
2,430
199
2,957
143
2,615
127
2,408
163
2,336
117
2,105
108
2,216
113
(15)%
(11)%
(15)%
(14)%
United Kingdom & Ireland
2,629
3,100
2,742
2,571
2,453
2,213
2,329
(15)%
(15)%
Savings
Protection
1,038
54
804
48
699
28
921
46
1,169
76
1,066
62
971
38
39%
36%
33%
30%
France
1,092
852
727
967
1,245
1,128
1,009
39%
33%
180
994
11
121
131
842
7
128
119
501
7
114
242
551
14
147
246
882
11
128
163
888
6
122
168
583
3
83
41%
16%
(57)%
(27)%
40%
12%
(59)%
(29)%
Poland, Italy, Spain & Other Europe
1,306
1,108
741
954
1,267
1,179
837
13%
9%
Europe
2,398
1,960
1,468
1,921
2,512
2,307
1,846
26%
21%
418
436
433
386
472
373
398
(8)%
(11)%
13
17
49
13
4
3
21
(57)%
(57)%
5,458
5,513
4,692
4,891
5,441
4,896
4,594
(2)%
(4)%
24
35
21
12
16
—
—
(100)%
(100)%
5,482
5,548
4,713
4,903
5,457
4,896
4,594
(3)%
(4)%
Present value of new business premiums2
Pensions
Savings
Annuities
Protection
Asia (excluding Malaysia & Sri Lanka)
Other business3
Total life and pensions sales – ongoing basis
Effect of disposals (Malaysia & Sri Lanka)
Total life and pensions sales
Sterling %
1 Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
2 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
3 Other business represents the results of Aviva Investors Pooled Pensions.
Local
currency %

10. 10
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement continued
7 – Geographical analysis of regular and single premiums – life and pensions sales (continuing operations1)
Regular premiums
9 months
2013 £m
Single premiums
WACF
Local
currency
growth
Present
value £m
9 months
2012 £m
WACF
Present value
£m
9 months
2013 £m
9 months
2012 £m
Local
currency
growth
United Kingdom
Ireland
United Kingdom & Ireland
France
Poland
Italy
Spain
Turkey
Other Europe
Europe
Asia – excluding Malaysia & Sri Lanka
Other
538
18
556
65
36
42
39
73
4
259
217
—
(6)%
(28)%
(7)%
18%
38%
(9)%
(19)%
83%
(79)%
11%
3%
—
4.8
4.6
4.8
8.3
7.4
5.8
5.7
4.1
1.5
6.1
5.4
—
2,608
83
2,691
538
268
243
222
299
6
1,576
1,164
—
572
25
597
53
25
44
46
41
19
228
205
—
5.2
3.9
5.1
6.9
7.6
5.5
5.8
4.2
5.1
5.9
5.2
—
2,968
98
3,066
367
189
244
266
173
96
1,335
1,073
—
4,049
255
4,304
2,844
90
1,508
591
42
14
5,089
79
28
5,034
371
5,405
2,304
85
1,359
668
39
36
4,491
214
79
(20)%
(34)%
(21)%
18%
1%
6%
(15)%
11%
(61)%
9%
(64)%
(65)%
Total life and pensions – ongoing
basis
1,032
(1)%
5.3
5,431
1,030
5.3
5,474
9,500
10,189
(9)%
2
(88)%
4.0
8
17
3.6
61
8
19
(58)%
1,034
(2)%
5.3
5,439
1,047
5.3
5,535
9,508
10,208
(9)%
Effect of disposals (Malaysia &
Sri Lanka)
Total life and pensions sales
1. Following the announced disposal of US Life in Q4 2012, it was no longer managed on a MCEV basis and it was no longer included in covered business. The sale of US Life was completed on 2 October 2013.
8 – Trend analysis of Investment sales (continuing operations) – cumulative
Growth on
3Q12 YTD
1Q12 YTD
£m
2Q12 YTD
£m
3Q12 YTD
£m
4Q12 YTD
£m
1Q13 YTD
£m
2Q13 YTD
£m
3Q13 YTD
£m
Sterling %
United Kingdom & Ireland
Aviva Investors
Asia
432
479
38
823
1,043
68
1,269
2,038
93
1,730
2,727
129
305
787
42
841
1,563
94
1,494
2,100
124
18%
3%
33%
18%
(1)%
31%
Total investment sales
949
1,934
3,400
4,586
1,134
2,498
3,718
9%
7%
Investment sales1
Local
currency %
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
9 – Trend analysis of Investment sales (continuing operations) – discrete
Growth on
3Q12
1Q12
Discrete
£m
2Q12
Discrete
£m
3Q12
Discrete
£m
4Q12
Discrete
£m
1Q13
Discrete
£m
2Q13
Discrete
£m
3Q13
Discrete
£m
United Kingdom & Ireland
Aviva Investors
Asia
432
479
38
391
564
30
446
995
25
461
689
36
305
787
42
536
776
52
653
537
30
46%
(46)%
20%
46%
(48)%
17%
Total investment sales
949
985
1,466
1,186
1,134
1,364
1,220
(17)%
(19)%
Investment sales1
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
Sterling %
Local
currency %

11. 11
Aviva plc
Interim Management Statement
07 November 2013
Statistical Supplement continued
10 – Trend analysis of general insurance and health net written premiums – cumulative
Growth on
3Q12 YTD
1Q12 YTD
£m
Health insurance
United Kingdom
Ireland
United Kingdom & Ireland
Europe
Asia
3Q12 YTD
£m
4Q12 YTD
£m
1Q13 YTD
£m
2Q13 YTD
£m
3Q13 YTD
£m
974
82
1,056
410
454
6
40
2,087
174
2,261
726
1,081
11
51
3,091
252
3,343
982
1,635
17
53
4,062
326
4,388
1,295
2,176
22
67
923
71
994
435
470
3
20
1,963
146
2,109
764
1,126
7
20
2,904
215
3,119
1,033
1,718
11
21
(6)%
(15)%
(7)%
5%
5%
(35)%
(60)%
(6)%
(18)%
(7)%
1%
5%
(36)%
(60)%
1,966
General insurance
United Kingdom
Ireland
United Kingdom & Ireland
Europe
Canada
Asia
Other
2Q12 YTD
£m
4,130
6,030
7,948
1,922
4,026
5,902
(2)%
(3)%
120
40
160
83
27
255
57
312
123
50
389
76
465
161
79
528
102
630
218
98
138
36
174
89
35
289
52
341
135
47
383
71
454
179
69
(2)%
(7)%
(2)%
11%
(13)%
(2)%
(10)%
(3)%
7%
(13)%
Sterling %
Local
currency %
270
Total
485
705
946
298
523
702
—
(2)%
2,236
4,615
6,735
8,894
2,220
4,549
6,604
(2)%
(3)%
11 – Trend analysis of general insurance and health net written premiums – discrete
Growth on
3Q12
1Q12
Discrete
£m
Health insurance
United Kingdom
Ireland
United Kingdom & Ireland
Europe
Asia
3Q12
Discrete
£m
4Q12
Discrete
£m
1Q13
Discrete
£m
2Q13
Discrete
£m
3Q13
Discrete
£m
974
82
1,056
410
454
6
40
1,113
92
1,205
316
627
5
11
1,004
78
1,082
256
554
6
2
971
74
1,045
313
541
5
14
923
71
994
435
470
3
20
1,040
75
1,115
329
656
4
—
941
69
1,010
269
592
4
1
(6)%
(12)%
(7)%
5%
7%
(33)%
(50)%
(6)%
(16)%
(7)%
1%
7%
(34)%
(50)%
1,966
General insurance
United Kingdom
Ireland
United Kingdom & Ireland
Europe
Canada
Asia
Other
2Q12
Discrete
£m
2,164
1,900
1,918
1,922
2,104
1,876
(1)%
(2)%
120
40
160
83
27
135
17
152
40
23
134
19
153
38
29
139
26
165
57
19
138
36
174
89
35
151
16
167
46
12
94
19
113
44
22
(30)%
—
(26)%
16%
(24)%
(30)%
(4)%
(27)%
11%
(25)%
Sterling %
Local
currency %
270
Total
215
220
241
298
225
179
(19)%
(20)%
2,236
2,379
2,120
2,159
2,220
2,329
2,055
(3)%
(4)%